This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its structure, featuring a trifluoromethyl group, is particularly valuable in drug development due to its ability to enhance the metabolic stability and bioavailability of therapeutic compounds. It is often employed in the production of medications targeting central nervous system disorders, including antidepressants and anxiolytics. Additionally, its chiral nature makes it useful in the creation of enantiomerically pure drugs, which are critical for achieving specific pharmacological effects while minimizing side effects. Researchers also explore its potential in developing novel compounds for treating chronic pain and neurodegenerative diseases.